To provide information about the experiential learning (EL) component of the new MPharm that will support prospective training practices in their decision to participate in the programme.
To provide an evidence based background to prescribing SGLT2 inhibitors, their updated indications and licensing thresholds including an opportunity for peer review and discussion of patient case studies.
To provide information about the experiential learning (EL) component of the new MPharm that will support prospective training practices in their decision to participate in the programme.
To optimise the use of Proton Pump Inhibitors (PPIs) in practice.
To provide information about the experiential learning (EL) component of the new MPharm that will support prospective training practices in their decision to participate in the programme.
To provide information about the experiential learning (EL) component of the new MPharm that will support prospective training practices in their decision to participate in the programme.
To provide an update of the current evidence base relating to the therapeutic management of asthma and COPD in primary care.
To provide an update of the current evidence base relating to the therapeutic management of asthma and COPD in primary care.
To enable pharmacists to effectively contribute to the shared care team delivering substitution therapy services in Northern Ireland.
To provide an update of the current evidence base relating to the therapeutic management of asthma and COPD in primary care.